Abstract
Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Current Respiratory Medicine Reviews
Title: Sleep and COPD
Volume: 5 Issue: 4
Author(s): Salim Surani
Affiliation:
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Abstract: Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Export Options
About this article
Cite this article as:
Surani Salim, Sleep and COPD, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112465
DOI https://dx.doi.org/10.2174/157339809790112465 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting
CNS & Neurological Disorders - Drug Targets PREFACE: “The Lower the Better” Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT
Current Hypertension Reviews Cardiovascular Effects of Flavonoids
Current Medicinal Chemistry The Use of Sensory Nerve Stimulation and Compression Bandaging to Improve Sensory Nerve Function and Healing of Chronic Venous Leg Ulcers
Current Aging Science The Epidemiology of Cardiovascular Disease in Adults with Type 1 Diabetes
Current Diabetes Reviews Factors Affecting Residual Platelet Aggregation in Prasugrel Treated Patients
Current Pharmaceutical Design Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry The Use of Novel Oral Anticoagulants in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Novel Therapeutic Agents for Hyperuricemia in Patients with Gout
Current Drug Therapy A New Role for Zn(II) Aminopeptidases: Antigenic Peptide Generation and Destruction
Current Pharmaceutical Design Adipokines: Therapeutic Targets for Metabolic Syndrome
Current Drug Targets Flaxseed for Health and Disease: Review of Clinical Trials
Combinatorial Chemistry & High Throughput Screening Recent Patents on Diacylglycerol Production and Applications
Recent Patents on Chemical Engineering Editorial from Guest Editor (Thematic Issue: Current Approach to COPD Management: Setting a Model in Medical Therapeutics)
Current Respiratory Medicine Reviews The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Functional Foods: Salient Features and Clinical Applications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Editorial [Hot Topic: Gender Differences in Cardiovascular Diseases. A Need for Action (Executive Guest Editors: Giuseppe Barbaro and Giuseppe M.C. Rosano)]
Current Pharmaceutical Design The Role of PKR as a Potential Target for Treating Cardiovascular Diseases
Current Cardiology Reviews The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry